Together with other GACD member agencies, NHMRC is inviting investigators to submit applications for implementation research that aims to improve the availability of effective, equitable, efficient, integrated, patient-centred, safe, and timely care for people living with multiple long-term conditions including non-communicable disease (MLTC NCD) in low- and middle-income countries (LMICs) and/or in disadvantaged populations in high-income countries (HICs).
For NHMRC funding support in HICs research must focus on Indigenous population groups. In Australia, research must focus on Aboriginal and/or Torres Strait Islander communities.
The objective of the NHMRC-GACD 2024 grant opportunity is to fund implementation research that will generate evidence about when, for whom, and under what circumstances, patient-centred approaches can improve integrated care for patients with MLTC NCD in LMICs and/or for patients in disadvantaged populations in HICs.
The intended outcomes of the NHMRC-GACD 2024 grant opportunity are to fund projects that will collectively: decrease the fragmentation of care for patients living with multiple chronic conditions, and ensure continuity of care across all stages of disease progression; expand the availability of effective, equitable, efficient, integrated, patient-centred, safe, and timely care for patients living with MLTC NCD; reduce health inequities; improve local capacity for implementation research, data collection and harmonisation, and stakeholder engagement for MLTC NCD management; and through successful achievement of the above objective, contribute to the United Nations Sustainable Development Goal 3.4 to reduce premature mortality from NCDs by one third by 2030.